Common Mutations at the Homocysteine Metabolism Pathway and Pediatric Stroke
- 1 April 2001
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 102 (2) , 115-120
- https://doi.org/10.1016/s0049-3848(01)00226-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in ChildrenStroke, 2000
- Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in ChildhoodBlood, 1999
- Factor V1691 G-A, Prothrombin 20210 G-A, and Methylenetetrahydrofolate Reductase 677 C-T Variants in Turkish Children With Cerebral InfarctJournal of Child Neurology, 1999
- Hyperhomocysteinemia as a Risk Factor for Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Topical Review Article: Etiology of Stroke in ChildrenJournal of Child Neurology, 1993
- Stroke in Children Within a Major Metropolitan Area: The Surprising Importance of Intracerebral HemorrhageJournal of Child Neurology, 1993
- Cerebrovascular Disorders of ChildhoodJournal of Child Neurology, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991